Priprema 11.2012.fh11 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 19, 2012, 11, 3513 – 3661 3577Kazalo podnositelja zahtjeva zaproširenje europskih prijava patenataPodnositelj europske MKP Broj objave europske Naziv izumaprijave patentaprijave patenta(71) (51) (97) (54)Arizona Board Of Regents For And On C12P 7/62 (2006.01) EP 2522735 Modified cyanobacteriaBehalf Arizona State University, US C12P 23/00 (2006.01)C12P 7/64 (2006.01)Baxter Healthcare SA, CH C12N 5/00 (2006.01) EP 2522717 Oligopeptide-free cell culture mediaBaxter International Inc, US C12N 5/00 (2006.01) EP 2522717 Oligopeptide-free cell culture mediaBiogen Idec MA Inc., US G01N 33/86 (2006.01) EP 2431746 Platelet aggregation assaysBoehringer Ingelheim InternationalGmbH, DEBoehringer Ingelheim InternationalGmbH, DEBoehringer Ingelheim InternationalGmbH, DEA61K 31/522 (2006.01)A61K 31/4985 (2006.01)A61P 3/10 (2006.01)A61P 9/04 (2006.01)A61K 9/50 (2006.01)A61K 31/428 (2006.01)A61K 9/50 (2006.01)A61K 31/428 (2006.01)EP 2397142EP 2431026EP 2431027Use of dpp iv inhibitorsExtended release pellet formulation containingPramipexole or a pharmaceutically acceptable saltthereof, method for manufacturing the same and usethereofExtended release pellet formulation containingPramipexole or a pharmaceutically acceptable saltthereof, method for manufacturing the same and usethereofBoehringer Ingelheim InternationalGmbH, DEC07D 475/00 (2006.01) EP 2436685 Method for producing annulated piperazine-2-onderivatives and intermediate products from the methodBoehringer Ingelheim Pharma GmbH & A61K 31/522 (2006.01) EP 2397142 Use of dpp iv inhibitorsCo. KG, DEA61K 31/4985 (2006.01)A61P 3/10 (2006.01)A61P 9/04 (2006.01)Boehringer Ingelheim Pharma GmbH &Co. KG, DEBoehringer Ingelheim Pharma GmbH &Co. KG, DEA61K 9/50 (2006.01)A61K 31/428 (2006.01)A61K 9/50 (2006.01)A61K 31/428 (2006.01)EP 2431026EP 2431027Extended release pellet formulation containingPramipexole or a pharmaceutically acceptable saltthereof, method for manufacturing the same and usethereofExtended release pellet formulation containingPramipexole or a pharmaceutically acceptable saltthereof, method for manufacturing the same and usethereofBoehringer Ingelheim Pharma GmbH & C07D 475/00 (2006.01) EP 2436685 Method for producing annulated piperazine-2-onCo. KG, DEderivatives and intermediate products from the methodBrown & Williamson Holdings, Inc., US A24D 3/08 (2006.01) EP 2510815 Selective filtration of cigarette smoke using chitosanderivativesCatalyst Biosciences, Inc., US A61K 38/48 (2006.01)A61P 29/00 (2006.01)A61P 25/28 (2006.01)A61P 9/10 (2006.01)A61K 38/49 (2006.01)EP 2428218 Modified proteases that inhibit complement activationConcannon, John Francis, IE A01K 61/00 (2006.01)B63B 22/16 (2006.01)B63B 22/18 (2006.01)B63B 22/04 (2006.01)Delphi Technologies Holding S.a.r.l., LU F02D 41/20 (2006.01)F02D 41/22 (2006.01)Egalet Ltd., GB A61K 9/16 (2006.01)A61J 7/00 (2006.01)A61K 31/167 (2006.01)A61K 33/26 (2006.01)A61K 31/4415 (2006.01)A61K 31/192 (2006.01)Elixir Medical Corporation, US A61K 31/436 (2006.01)A61F 2/00 (2006.01)A61K 9/00 (2006.01)A61K 31/453 (2006.01)A61K 31/787 (2006.01)A61P 9/00 (2006.01)A61K 47/00 (2006.01)A61L 27/34 (2006.01)A61L 27/54 (2006.01)A61L 29/08 (2006.01)A61L 31/10 (2006.01)A61L 31/16 (2006.01)A61L 29/16 (2006.01)A61L 31/00 (2006.01)A61F 2/90 (2006.01)A61F 2/92 (2006.01)EP 2520163EP 2428670EP 2258349EP 2431036A float and a floatable structureDrive circuit for an injector arrangement and diagnosticmethodSwellable dosage form comprising gellan gumMacrocyclic lactone compounds and methods for theiruseISSN 1847-3024